You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • P95 First two US patients with lupus nephritis (LN) treated with anti-CD19 chimeric antigen receptor (CAR) T-cell therapy: preliminary results from the KYSA-1 phase 1, multicenter study of KYV-101

Citation Tools

Article menu

Download PDFPDF

Poster Presentations
P95 First two US patients with lupus nephritis (LN) treated with anti-CD19 chimeric antigen receptor (CAR) T-cell therapy: preliminary results from the KYSA-1 phase 1, multicenter study of KYV-101

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Podoll A, Furie R, Kim F, et al
P95 First two US patients with lupus nephritis (LN) treated with anti-CD19 chimeric antigen receptor (CAR) T-cell therapy: preliminary results from the KYSA-1 phase 1, multicenter study of KYV-101
Lupus Science & Medicine 2024;11:doi: 10.1136/lupus-2024-el.149